Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. - Wikidata - wikimedia - TriplyDB

Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.

Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.

http://www.wikidata.org/entity/Q46790380

about

Kynurenine is an endothelium-derived relaxing factor produced during inflammation The physiological action of picolinic Acid in the human brain Inflammation in depression: is adiposity a cause?Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis Quinolinic acid, the inescapable neurotoxin Kynurenines in the mammalian brain: when physiology meets pathology Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease Inflammatory-induced hibernation in the fetus: priming of fetal sheep metabolism correlates with developmental brain injury Human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD): a structural and mechanistic unveiling Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.Early activation of the kynurenine pathway predicts early death and long-term outcome in patients resuscitated from out-of-hospital cardiac arrest The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2(+/-) mice, using liquid chromatography-tandem mass spectrometry.The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*.Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus.The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection.Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin.Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms.The kynurenine pathway in stem cell biology.The common inflammatory etiology of depression and cognitive impairment: a therapeutic target.The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities.Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic Acid The kynurenine pathway and the brain: Challenges, controversies and promises.Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis.The role of tryptophan metabolism in postpartum depression.Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1.Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.

P2860

Q24630488-E8F58B24-3CB4-4190-A2F4-EB52B4392436 Q24634995-6662E528-FEF7-4535-8F1B-AF895DF93C1C Q24635451-20FD6E22-2E19-414B-90A7-1DB161539E9D Q26740330-BBAF9A38-6A08-48BF-AFA4-BB47824C7913 Q26991715-0AB80983-4AC2-4A73-BDE5-F448C8F06795 Q27003296-DD22E406-37F4-478F-9250-C3B9F2072055 Q27011505-B2AC6726-F1ED-4087-BA7E-1A351AAA0403 Q27310505-FD314705-6E39-4BCB-A073-1D5CF233A41F Q28115413-3DD90538-A0EA-464D-A987-72C4CB04ADA7 Q33572850-0A6911F6-1A7B-474C-BC0F-C0DA92958D93 Q33751166-35244243-1AB5-4966-85CF-22AB54F79A8A Q34090453-56D618C3-BFCF-4A3B-AB44-151FB2E7ED48 Q34248380-B6A1B592-9D57-477F-8E7D-A90E46E7840E Q34997869-8A918E35-CBB3-4F91-8FD9-950152FB6983 Q35026406-B7255A72-9805-453E-AC44-389D4E107420 Q35029070-153FAB80-4602-4FA8-984D-06D30D72F602 Q35156136-3A7E2DFA-8CEA-4C18-B8BE-A54789BA9224 Q35366778-7E272D31-60D0-4E6C-87C6-0398CA0E25E5 Q36131465-BCC99245-8081-4D5D-9849-0074BEB5A158 Q36763697-6276411F-CC95-435A-83A7-AD782CCDF018 Q36865674-2A3CBB02-05F0-49B5-B202-53DC65AE9599 Q37318862-F388AE2B-7CF7-4657-BA99-93AC308ED38E Q37726311-FCA4FD20-1F39-49D4-BA1C-A54AE56E5137 Q37813804-32C39E9E-3459-4345-B830-B209CD0434D5 Q37992617-B56C0D98-8CB3-425E-AA32-0A0AE80645E3 Q38149123-374334AE-49FD-4962-A358-D545CEC0E892 Q38245307-2E304A83-E864-48F0-8653-75239217333F Q38675915-7D760EC9-4D71-423D-A5B3-680B2D825CC7 Q38729027-24D4F07B-98DD-4138-822C-DEC5FC18184A Q38832497-D7C9659A-BE96-4BCE-85AD-9F0EEFC736CE Q39616472-FA7C11A0-4419-4232-AFCD-3A8F2289D422 Q47201558-2C896AA6-79C6-4D8E-A3A6-AD8B68C80AF0 Q50532036-C1826C13-4C7D-46C5-BED6-0BC01683FA3A Q52725478-EBEA7F16-BAEE-4BBE-A318-EF21C5D3A5B8 Q55381445-D6D936C6-3DE9-451F-B5D7-A31CCAF86BCE

P2860

Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.

http://www.wikidata.org/entity/Q46790380

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.

@en

Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.

@nl

type

label

Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.

@en

Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.

@nl

prefLabel

Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.

@en

Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.

@nl

P1433

Q46790380-CA1E6877-8DC4-449F-951F-C6A456E1200F

P1476

Q46790380-B803B4D3-A519-4AA7-AAE1-7AC83E27C31C

P2093

Q46790380-0483F9CA-F1C1-4CFA-9A5E-BBED3C178CBD

Q46790380-060D1CFD-92FF-414E-848F-436EF864779F

Q46790380-73A29D9D-D3FC-46D0-B675-03DFAF61AF65

Q46790380-7C8BC94A-149B-4B56-BB7D-726B41DB39C8

Q46790380-7ED45FB6-971A-4B83-93B8-5F6F2D11FA97

Q46790380-9FEB0CCD-1EAB-4A63-9EE5-6F5F4611B75D

Q46790380-AAAADCDA-EEE3-481D-8684-2F8E662EE6E8

Q46790380-D33AE3C7-F7C3-4ED7-9D03-B4C12F702F96

P2860

Q46790380-0E02F881-EA9C-488E-80E5-208EB079F91F

Q46790380-0FB168C5-C89A-421F-A917-5D140271EAC8

Q46790380-17BD6865-A3D8-41A1-BD00-B6BEB91A1510

Q46790380-27DE9F43-4008-4409-BA4F-840A643801CE

Q46790380-2E18ACC0-5533-48C0-A388-3C02560FC535

Q46790380-30F0F209-7CF3-4006-B946-7A6B17B40515

Q46790380-32CFC63F-EADC-40BE-8F94-28E6A9E1CA79

Q46790380-35827A23-07F5-4CD6-A159-001A3FF0F250

Q46790380-49F56327-F5EC-4303-A095-1204FFBF2556

Q46790380-4E3DCAA8-B400-41F8-A20C-330E7931667F

P304

Q46790380-15074339-75D8-449C-8C5F-9EC687883DC4

P31

Q46790380-9C8F6AE0-A7C0-4DE7-8C03-051DDD17F7DB

P356

Q46790380-8288C99E-E52E-4DB4-8C2A-BB37F6D73602

P407

Q46790380-2934F84C-CEA7-44C1-A1F5-7D5840763BBE

P433

Q46790380-7495090D-A6BF-4524-BBBC-D8FB5FD68E15

P478

Q46790380-DEBC7EC8-0E9D-476F-BF08-B574C39B04BF

P50

Q46790380-183B4AED-9803-4183-92CD-B8D3B8C7431E

P577

Q46790380-8C790A1B-F78D-47AB-B443-2CD3EFCF8E64

P5875

Q46790380-89D4C9EE-3760-49EB-AAA9-03367B010CF6

P698

Q46790380-03B3FC46-29A8-4EEB-B2F0-F08CDC6F36BE

P921

Q46790380-65992EC7-DF96-40CE-AEE7-9F0FB81F9B67

P356

J.1471-4159.2008.05241.X

P1433

Journal of Neurochemistry

P1476

Kynurenine pathway metabolism ...... ne tolerance and neurotoxicity

@en

P2093

David Walker

http://www.w3.org/2001/XMLSchema#string

George Smythe

http://www.w3.org/2001/XMLSchema#string

Muhammad Mukhtar

http://www.w3.org/2001/XMLSchema#string

Nicole L Webster

http://www.w3.org/2001/XMLSchema#string

Patricia J Armati

http://www.w3.org/2001/XMLSchema#string

Robert Owe-Young

http://www.w3.org/2001/XMLSchema#string

Roger J Pomerantz

http://www.w3.org/2001/XMLSchema#string

Suzanne M Crowe

http://www.w3.org/2001/XMLSchema#string

P2860

Tolerance, DCs and tryptophan: much ado about IDO

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse

Inhibition of indoleamine 2,3 dioxygenase activity by H2O2.

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection.

The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages.

Mechanisms of intracellular killing of Rickettsia conorii in infected human endothelial cells, hepatocytes, and macrophages.

Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.

Endogenous kynurenines as targets for drug discovery and development.

The pharmacological manipulation of glutamate receptors and neuroprotection.

Activity of picolinic acid in combination with the antiprotozoal drug quinacrine against Mycobacterium avium complex.

P304

1346-1357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1471-4159.2008.05241.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5631195

http://www.w3.org/2001/XMLSchema#string

P698

18221377

http://www.w3.org/2001/XMLSchema#string

P921